ERK1/2 Inhibition Alleviates Noise-Induced Hearing Loss While Tempering Down the Immune Response

por Lutze, Richard D., Ingersoll, Matthew A., Thotam, Alena, Joseph, Anjali, Fernandes, Joshua, Teitz, Tal
Publicado 2023

BRAF inhibition protects against hearing loss in mice

por Ingersoll, Matthew A., Malloy, Emma A., Caster, Lauryn E., Holland, Eva M., Xu, Zhenhang, Zallocchi, Marisa, Currier, Duane, Liu, Huizhan, He, David Z.Z., Min, Jaeki, Chen, Taosheng, Zuo, Jian, Teitz, Tal
Publicado 2020

Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment

por Teitz, Tal, Stanke, Jennifer J., Federico, Sara, Bradley, Cori L., Brennan, Rachel, Zhang, Jiakun, Johnson, Melissa D., Sedlacik, Jan, Inoue, Madoka, Zhang, Ziwei M., Frase, Sharon, Rehg, Jerold E., Hillenbrand, Claudia M., Finkelstein, David, Calabrese, Christopher, Dyer, Michael A., Lahti, Jill M.
Publicado 2011

CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss

por Teitz, Tal, Fang, Jie, Goktug, Asli N., Bonga, Justine D., Diao, Shiyong, Hazlitt, Robert A., Iconaru, Luigi, Morfouace, Marie, Currier, Duane, Zhou, Yinmei, Umans, Robyn A., Taylor, Michael R., Cheng, Cheng, Min, Jaeki, Freeman, Burgess, Peng, Junmin, Roussel, Martine F., Kriwacki, Richard, Guy, R. Kiplin, Chen, Taosheng, Zuo, Jian
Publicado 2018